Artini Holdings Limited (Stock Code: 789) announced its unaudited results for the six months ended 30 September 2025. Total revenue reached approximately HK$67.36 million, marking a 24.4% increase compared to the HK$54.16 million recorded in the same period of 2024. The company’s gross profit rose to about HK$14.94 million, up 30.1% year on year, with its overall gross margin slightly improving from 21.2% to 22.2%.

During the reporting period, the surge in sales from the skincare and health product sales platform business contributed significantly to revenue growth, counterbalancing lower revenues in the fashion accessories platform segment. Selling and distribution expenses saw a decrease to HK$7.64 million, largely attributed to the company's measures on cost management. Administrative expenses also declined to HK$7.71 million as a result of reduced staff and professional fees.

Despite the revenue and margin improvements, Artini recorded a net loss of approximately HK$1.71 million, reversing from a net profit of HK$1.07 million in the prior-year period. Management attributed this swing partly to the absence of a one-off gain recognized from a subsidiary deregistration that benefitted last year’s results.

The announcement highlights the Group’s stance of closely monitoring global economic headwinds and challenges, alongside plans to refine its marketing strategies to bolster offline presence while integrating online channels. The Group also intends to diversify its product offerings in fashion accessories, skincare, and health-oriented items, aligning with evolving consumer demand and market conditions.